You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 1, January 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (452)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Tremor
 •Alert me on articles by topic

Diagnostic Criteria for Parkinson Disease

Douglas J. Gelb, MD, PhD; Eugene Oliver, PhD; Sid Gilman, MD

Arch Neurol. 1999;56:33-39.

The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria. We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD. Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible. The diagnoses of Possible and Probable PD are based on clinical criteria alone. Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD. Criteria for histopathologic confirmation of PD are also presented.


From the Department of Neurology, University of Michigan, Ann Arbor (Drs Gelb and Gilman); and the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md (Dr Oliver).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(1):129-131.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidental Lewy Body Disease and Preclinical Parkinson Disease
DelleDonne et al.
Arch Neurol 2008;65:1074-1080.
ABSTRACT | FULL TEXT  

Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation
Nolano et al.
Brain 2008;131:1903-1911.
ABSTRACT | FULL TEXT  

Determinants of disability and quality of life in mild to moderate Parkinson disease
Muslimovic et al.
Neurology 2008;70:2241-2247.
ABSTRACT | FULL TEXT  

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll et al.
Neurology 2008;70:1456-1460.
ABSTRACT | FULL TEXT  

Parkinson's disease: clinical features and diagnosis
Jankovic
J. Neurol. Neurosurg. Psychiatry 2008;79:368-376.
ABSTRACT | FULL TEXT  

Altered Diffusion in the Frontal Lobe in Parkinson Disease
Karagulle Kendi et al.
Am. J. Neuroradiol. 2008;29:501-505.
ABSTRACT | FULL TEXT  

Differential Effects of Black versus Green Tea on Risk of Parkinson's Disease in the Singapore Chinese Health Study
Tan et al.
Am J Epidemiol 2008;167:553-560.
ABSTRACT | FULL TEXT  

The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease
Weisscher et al.
Neurology 2007;69:2155-2161.
ABSTRACT | FULL TEXT  

Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide
McKeith
PN 2007;7:374-382.
ABSTRACT | FULL TEXT  

Motor procedural learning in Parkinson's disease
Muslimovic et al.
Brain 2007;130:2887-2897.
ABSTRACT | FULL TEXT  

Test-Retest Reliability of 24 Hours of Activity Monitoring in Individuals With Parkinson's Disease in Home and Community
White et al.
Neurorehabil Neural Repair 2007;21:327-340.
ABSTRACT  

TDP-43 in Familial and Sporadic Frontotemporal Lobar Degeneration with Ubiquitin Inclusions
Cairns et al.
Am. J. Pathol. 2007;171:227-240.
ABSTRACT | FULL TEXT  

Prevalence of haemochromatosis gene mutations in Parkinson's disease
Aamodt et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:315-317.
ABSTRACT | FULL TEXT  

How common are the "common" neurologic disorders?
Hirtz et al.
Neurology 2007;68:326-337.
ABSTRACT | FULL TEXT  

Limb-kinetic apraxia in Parkinson disease
Quencer et al.
Neurology 2007;68:150-151.
ABSTRACT | FULL TEXT  

PINK1 mutation heterozygosity and the risk of Parkinson's disease
Toft et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:82-84.
ABSTRACT | FULL TEXT  

Early Abnormalities of Vascular and Cardiac Autonomic Control in Parkinson's Disease Without Orthostatic Hypotension
Barbic et al.
Hypertension 2007;49:120-126.
ABSTRACT | FULL TEXT  

Differences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard et al.
Neurology 2006;67:1931-1934.
ABSTRACT | FULL TEXT  

PET Measurement of Cardiac and Nigrostriatal Denervation in Parkinsonian Syndromes
Raffel et al.
JNM 2006;47:1769-1777.
ABSTRACT | FULL TEXT  

A specific clinical pattern of camptocormia in Parkinson's disease
Lepoutre et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1229-1234.
ABSTRACT | FULL TEXT  

Clinical Heterogeneity of the LRRK2 G2019S Mutation.
Papapetropoulos et al.
Arch Neurol 2006;63:1242-1246.
ABSTRACT | FULL TEXT  

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore et al.
JAMA 2006;296:661-670.
ABSTRACT | FULL TEXT  

Clinical Features and Gene Analysis in Korean Patients With Early-Onset Parkinson Disease.
Chung et al.
Arch Neurol 2006;63:1170-1174.
ABSTRACT | FULL TEXT  

Escitalopram for Major Depression in Parkinson's Disease: An Open-Label, Flexible-Dosage Study
Weintraub et al.
J. Neuropsychiatry Clin. Neurosi. 2006;18:377-383.
ABSTRACT | FULL TEXT  

Pain and motor complications in Parkinson's disease
Tinazzi et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:822-825.
ABSTRACT | FULL TEXT  

Is it Parkinson's disease, and if not, what is it?
Taylor and Counsell
PN 2006;6:154-165.
FULL TEXT  

Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky et al.
Neurology 2006;66:968-975.
ABSTRACT | FULL TEXT  

LRRK2 Mutations in Spanish Patients With Parkinson Disease: Frequency, Clinical Features, and Incomplete Penetrance.
Gaig et al.
Arch Neurol 2006;63:377-382.
ABSTRACT | FULL TEXT  

Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population
Toft et al.
Neurology 2006;66:415-417.
ABSTRACT | FULL TEXT  

Heterogeneous Phenotype in a Family With Compound Heterozygous Parkin Gene Mutations
Deng et al.
Arch Neurol 2006;63:273-277.
ABSTRACT | FULL TEXT  

Evaluation of physical therapy in parkinsonian patients with freezing of gait: a pilot study
Brichetto et al.
Clin Rehabil 2006;20:31-35.
ABSTRACT  

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial
Ondo et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1636-1639.
ABSTRACT | FULL TEXT  

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease
Skipper et al.
Hum Mol Genet 2005;14:3549-3556.
ABSTRACT | FULL TEXT  

Association of homocysteine with plasma amyloid {beta} protein in aging and neurodegenerative disease
Irizarry et al.
Neurology 2005;65:1402-1408.
ABSTRACT | FULL TEXT  

{alpha}-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Halliday et al.
Brain 2005;128:2654-2664.
ABSTRACT | FULL TEXT  

A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr et al.
Brain 2005;128:2665-2674.
ABSTRACT | FULL TEXT  

Cognitive profile of patients with newly diagnosed Parkinson disease
Muslimovic et al.
Neurology 2005;65:1239-1245.
ABSTRACT | FULL TEXT  

A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease
Halliday et al.
Brain 2005;128:2272-2280.
ABSTRACT | FULL TEXT  

Diagnosis and Initial Management of Parkinson's Disease
Nutt and Wooten
NEJM 2005;353:1021-1027.
FULL TEXT  

Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease
Deng et al.
Neurology 2005;65:651-652.
FULL TEXT  

Camptocormia: Pathogenesis, classification, and response to therapy
Azher and Jankovic
Neurology 2005;65:355-359.
ABSTRACT | FULL TEXT  

Searching for a relationship between manganese and welding and Parkinson's disease
Jankovic
Neurology 2005;64:2021-2028.
ABSTRACT | FULL TEXT  

Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy
Cordato et al.
Brain 2005;128:1259-1266.
ABSTRACT | FULL TEXT  

Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak et al.
Neurology 2005;64:1404-1410.
ABSTRACT | FULL TEXT  

A Rare Truncating Mutation in ADH1C (G78Stop) Shows Significant Association With Parkinson Disease in a Large International Sample
Buervenich et al.
Arch Neurol 2005;62:74-78.
ABSTRACT | FULL TEXT  

Parkin Mutations and Early-Onset Parkinsonism in a Taiwanese Cohort
Wu et al.
Arch Neurol 2005;62:82-87.
ABSTRACT | FULL TEXT  

Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz et al.
NEJM 2004;351:1972-1977.
ABSTRACT | FULL TEXT  

(123I) {beta}-CIT and Single-Photon Emission Computed Tomographic Imaging vs Clinical Evaluation in Parkinsonian Syndrome: Unmasking an Early Diagnosis
Jennings et al.
Arch Neurol 2004;61:1224-1229.
ABSTRACT | FULL TEXT  

Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians
Tan et al.
Neurology 2004;62:1999-2004.
ABSTRACT | FULL TEXT  

Elevated Plasma Homocysteine Level in Patients With Parkinson Disease: Motor, Affective, and Cognitive Associations
O'Suilleabhain et al.
Arch Neurol 2004;61:865-868.
ABSTRACT | FULL TEXT  

Assessing the Executive Function Deficits of Patients with Parkinson's Disease: Utility of the Tower of London-Drexel
Culbertson et al.
Assessment 2004;11:27-39.
ABSTRACT  

Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
Weng et al.
JNM 2004;45:393-401.
ABSTRACT | FULL TEXT  

DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function
Lockhart et al.
J. Med. Genet. 2004;41:e22-22.
FULL TEXT  

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial
Esselink et al.
Neurology 2004;62:201-207.
ABSTRACT | FULL TEXT  

Recognition and Treatment of Depression in Parkinson's Disease
Weintraub et al.
J Geriatr Psychiatry Neurol 2003;16:178-183.
ABSTRACT  

Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey
Henderson et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:956-958.
ABSTRACT | FULL TEXT  

Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson's Disease Patients
Huang et al.
JNM 2003;44:999-1005.
ABSTRACT | FULL TEXT  

Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies
Ihara et al.
J. Biol. Chem. 2003;278:24095-24102.
ABSTRACT | FULL TEXT  

Identifying the Pattern of Olfactory Deficits in Parkinson Disease Using the Brief Smell Identification Test
Double et al.
Arch Neurol 2003;60:545-549.
ABSTRACT | FULL TEXT  

Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease
Riley and Chelimsky
J. Neurol. Neurosurg. Psychiatry 2003;74:56-60.
ABSTRACT | FULL TEXT  

Cognitive slowing in Parkinson's disease resolves after practice
Press et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:524-528.
ABSTRACT | FULL TEXT  

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease
Harding et al.
Brain 2002;125:2431-2445.
ABSTRACT | FULL TEXT  

Functional association of the parkin gene promoter with idiopathic Parkinson's disease
West et al.
Hum Mol Genet 2002;11:2787-2792.
ABSTRACT | FULL TEXT  

Comparison of Healthcare Utilization and Direct Costs in Three Degenerative Dementias
Murman et al.
AJGP 2002;10:328-336.
ABSTRACT | FULL TEXT  

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:708-712.
ABSTRACT | FULL TEXT  

Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease
Xu et al.
Neurology 2002;58:881-884.
ABSTRACT | FULL TEXT  

Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy
Cordato et al.
Brain 2002;125:789-800.
ABSTRACT | FULL TEXT  

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding et al.
Brain 2002;125:391-403.
ABSTRACT | FULL TEXT  

Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000
Galasko et al.
Neurology 2002;58:90-97.
ABSTRACT | FULL TEXT  

Pathophysiology of slow vertical saccades in progressive supranuclear palsy
Bhidayasiri et al.
Neurology 2001;57:2070-2077.
ABSTRACT | FULL TEXT  

Barriers to Treatment: The Unique Challenges for Physicians Providing Dementia Care
Foster
J Geriatr Psychiatry Neurol 2001;14:188-198.
ABSTRACT  

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
Hughes et al.
Neurology 2001;57:1497-1499.
ABSTRACT | FULL TEXT  

Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging
Huang et al.
JNM 2001;42:1303-1308.
ABSTRACT | FULL TEXT  

{alpha}-synuclein gene haplotypes are associated with Parkinson's disease
Farrer et al.
Hum Mol Genet 2001;10:1847-1851.
ABSTRACT | FULL TEXT  

Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD
Wang et al.
Neurology 2001;56:1757-1759.
ABSTRACT | FULL TEXT  

Lesion of thalamic centromedian- parafascicular complex after chronic deep brain stimulation
Henderson et al.
Neurology 2001;56:1576-1579.
ABSTRACT | FULL TEXT  

Examination of motor output pathways in patients with corticobasal ganglionic degeneration using transcranial magnetic stimulation
Valls-Sole et al.
Brain 2001;124:1131-1137.
ABSTRACT | FULL TEXT  

Differential Diagnosis of Parkinson's Disease and Vascular Parkinsonism by 99mTc-TRODAT-1
Tzen et al.
JNM 2001;42:408-413.
ABSTRACT | FULL TEXT  

Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies
Duda et al.
Am. J. Pathol. 2000;157:1439-1445.
ABSTRACT | FULL TEXT  

Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications
Henderson et al.
Brain 2000;123:1410-1421.
ABSTRACT | FULL TEXT  

Defining Diastolic Heart Failure : A Call for Standardized Diagnostic Criteria
Vasan and Levy
Circulation 2000;101:2118-2121.
FULL TEXT  

Progressive dementia and gait disorder in a 78 year old woman
Tagliati et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:526-531.
FULL TEXT  

Polymorphism of NACP-Rep1 in Parkinson's disease: An etiologic link with essential tremor?
Tan et al.
Neurology 2000;54:1195-1198.
ABSTRACT | FULL TEXT  

The Evolution of Diagnosis in Early Parkinson Disease
Jankovic et al.
Arch Neurol 2000;57:369-372.
ABSTRACT | FULL TEXT  

Neuropsychiatric Aspects of Parkinson's Disease
Marsh
Psychosomatics 2000;41:15-23.
ABSTRACT | FULL TEXT  

Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky et al.
Neurology 2006;66:968-975.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.